Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 41Prostatic Neoplasms 32Ovarian Neoplasms 23Testicular Neoplasms 18Carcinoma, Transitional Cell 16Carcinoma, Renal Cell 16Carcinoma, Non-Small-Cell Lung 15Neoplasms 13Melanoma 13Testicular Germ Cell Tumor 12Colorectal Neoplasms 12Breast Neoplasms 12Neoplasm Metastasis 10Urethral Neoplasms 9Stomach Neoplasms 9Lung Neoplasms 9Endodermal Sinus Tumor 9Teratoma 8Pancreatic Neoplasms 8Central Nervous System Neoplasms 8Carcinoma, Embryonal 8Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Seminoma 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Esophageal Neoplasms 5Endometrial Neoplasms 5Penile Neoplasms 4

Interventions

Gemcitabine 4Cisplatin 4pembrolizumab 3Carboplatin 3erdafitinib 2durvalumab 2vinflunine 1tremelimumab 1niraparib 1enfortumab vedotin 1cabozantinib 1avelumab 1atezolizumab 1Tiragolumab 1Sunitinib 1Radiotherapy 1Radiation Dose Hypofractionation 1Paclitaxel 1Nivolumab 1Midazolam 1Metformin 1Ipilimumab 1Everolimus 1Docetaxel 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urothelial Cancer × Paclitaxel × Genitourinary × Clear all
NCT02033993 2023-08-22

Nab-Paclitaxel to Paclitaxel in Advanced Urothelial Cancer Progressing on or After Platinum Containing Regimen.

Canadian Cancer Trials Group

Phase 2 Completed
199 enrolled 14 charts
Genitourinary

Urothelial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡